Micronutrient Consequences of Long Term Proton Pump Inhibitor Therapy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Advances in Medicine and Medical Research

• Publication date

  2017-01-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.9734/JAMMR/2017/34805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypomagnesemia Among Outpatient Long-Term Proton Pump Inhibitor Users

  2017cited by this paper
• Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency.

  2017cited by this paper
• Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.

  2016cited by this paper
• Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.

  2016cited by this paper
• Long‐term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies

  2015cited by this paper
• Increased Risk of Microscopic Colitis With Use of Proton Pump Inhibitors and Non-Steroidal Anti-Inflammatory Drugs

  2015cited by this paper
• Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?

  2015cited by this paper
• The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia: A Systematic Review and Meta-Analysis

  2014cited by this paper
• Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites.

  2014cited by this paper
• Use of proton pump inhibitors is associated with anemia in cardiovascular outpatients.

  2014cited by this paper
• Proton Pump Inhibitors and Hospitalization with Hypomagnesemia: A Population-Based Case-Control Study

  2014cited by this paper
• Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors

  2013cited by this paper
• Perils and pitfalls of long-term effects of proton pump inhibitors

  2013cited by this paper
• Proton pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: a prospective matched controlled study.

  2013cited by this paper
• Proton Pump Inhibitor–Associated Hypomagnesemia: What Do FDA Data Tell Us?

  2013cited by this paper
• Uses of proton pump inhibitors and hypomagnesemia

  2012cited by this paper
• Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection

  2012cited by this paper
• Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study

  2012cited by this paper
• Association between Proton Pump Inhibitor Therapy and Clostridium difficile Infection: A Contemporary Systematic Review and Meta-Analysis

  2012cited by this paper
• Vitamin C, Gastritis, and Gastric Disease: A Historical Review and Update

  2012cited by this paper
• Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis

  2011cited by this paper
• Does a proton pump inhibitor cause hypokalemia?

  2011cited by this paper
• Effects of long‐term PPI treatment on producing bowel symptoms and SIBO

  2011cited by this paper
• Association Between Proton Pump Inhibitor Use and Anemia: A Retrospective Cohort Study

  2011cited by this paper
• Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.

  2010cited by this paper
• Gastric acid suppressants--too much of a good thing?

  2010cited by this paper
• Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women.

  2009cited by this paper
• Magnesium supplementation and osteoporosis.

  2009cited by this paper
• CLINICAL IMPLICATIONS OF CHRONIC THERAPY FOR GERD

  2009cited by this paper
• Prevalence of anaemia in older persons: systematic review

  2008cited by this paper
• Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors

  2008cited by this paper
• Severe hypomagnesaemia in long‐term users of proton‐pump inhibitors

  2008cited by this paper
• Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis

  2007cited by this paper
• Risk factors of vitamin B(12) deficiency in patients receiving metformin.

  2006cited by this paper
• Long-term proton pump inhibitor therapy and risk of hip fracture.

  2006cited by this paper
• Proton-pump inhibitors and hypomagnesemic hypoparathyroidism.

  2006cited by this paper
• Proton pump inhibitors reduce the bioavailability of dietary vitamin C

  2005cited by this paper
• Effect of Omeprazole on Oral Iron Replacement in Patients with Iron Deficiency Anemia

  2004cited by this paper
• A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults.

  2004cited by this paper
• Increased Vitamin B12 Requirement Associated with Chronic Acid Suppression Therapy

  2003cited by this paper
• Magnesium metabolism and its disorders.

  2003cited by this paper
• Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice.

  1999cited by this paper
• Effect of L-lactic acid on calcium absorption in rats fed omeprazole.

  1998cited by this paper
• Iron absorption in patients with Zollinger–Ellison syndrome treated with long‐term gastric acid antisecretory therapy

  1998cited by this paper
• Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans.

  1995cited by this paper
• Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humans

  1993cited by this paper
• Serum Iron, Ferritin, and Vitamin B12 During Prolonged Omeprazole Therapy

  1992cited by this paper
• Role of gastric acid in food iron absorption.

  1981cited by this paper

• Gastroesophageal reflux disease management and chronic use of proton pump inhibitors

  2023cites this paper